ViiV HQ
Pharma

ViiV girds data package for Cabenuva in competitive HIV market

Cabenuva hit superior viral suppression versus oral antiretrovirals in adults and adolescents with HIV-1 with viremia in the phase 3b Crown study.
Fraiser Kansteiner Oct 6, 2026 10:59am
For biopharma manufacturing at speed and scale the future is flexible

For biopharma manufacturing at speed and scale, the future is flexible

Brought to you by Resilience
business competition

AbbVie and Genmab’s Epkinly combo scores first-line DLBCL win

Oct 6, 2026 9:11am
Advancing Treatment A Closer Look at ADT Darolutamide with Dr Rana McKay

Advancing mCSPC Treatment: A Closer Look at ADT + Darolutamide with Dr. Rana McKay

Brought to you by Bayer
radiopharmaceutical

Proposed nuclear rules threaten Novartis’ Pluvicto

Oct 6, 2026 9:00am
Genentech archival photos

Genentech opens its history books in 50 year anniversary doc

Oct 6, 2026 9:00am
More News

BD snags tariff relief with $19B US investment pledge

Oct 6, 2026 7:42am

Gilead rolls out disease-specific wellness tools with Calm app

Oct 5, 2026 11:57am

Shionogi acquires IntraBio to bolster rare disease business

Oct 5, 2026 11:33am

Novo cites production site corrections amid hemophilia FDA delay

Oct 5, 2026 7:15am